This inventor holds 2 USPTO granted patents. Top assignee: The Wistar Institute. Active years: 1997.
Location History:
- Brookfield, WI (US) (1997)
- Wilmington, DE (US) (1997)
Company Filing History:
Years Active: 1997
Title: The Innovative Contributions of Jennifer Morris
Introduction
Jennifer Morris is a prominent inventor based in Brookfield, WI (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of 2 patents to her name, her work has the potential to impact the diagnosis and treatment of various malignancies.
Latest Patents
Jennifer's latest patents include the development of WT1 monoclonal antibodies and methods of use therefor. The present invention provides three unique monoclonal antibodies directed against a portion of the Wilms' tumor antigen. These antibodies are instrumental in detecting, monitoring, and diagnosing malignancies characterized by over-expression or inappropriate expression of the WT1 protein. The monoclonal antibodies, each having an epitope located in amino acids 1-181 of the WT1 tumor protein, have been constructed along with the hybridomas that secrete them. This innovation is crucial for the medical community in the fight against cancers associated with the WT1 protein.
Career Highlights
Jennifer Morris is affiliated with The Wistar Institute, where she continues her groundbreaking research. Her work has garnered attention for its potential applications in cancer diagnostics and treatment.
Collaborations
Some of her notable coworkers include Meenhard Herlyn and Frank J Rauscher, III. Their collaborative efforts contribute to the advancement of research in the field of oncology.
Conclusion
Jennifer Morris exemplifies the spirit of innovation in biomedical research. Her contributions through her patents and collaborations are paving the way for advancements in cancer detection and treatment.